Development of Perfluorochemicals in Cardiovascular Surgery
全氟化合物在心血管外科中的发展
基本信息
- 批准号:09470278
- 负责人:
- 金额:$ 4.74万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This study was designed to assess the effect of Perfluorotributylamine/Pluronic F-68 Stem-Emulsion (FC43se) administration on post-ischemic cardiac function after CPB (cardiopulmonary bypass).(Methods) After 60min CPB, the beagle dog heart was submitted to warm ischemia state for 30min at 36゚C.Then the heart was made to resume heart beating. Experimental groups were divided into two groups. In control(C) group (n=19) and FC43se-administration (FC) group (n=14), 10m1 of saline and FC43se were infused into aortic root just before aortic unclamping, respectively. The physiological parameters of left ventncular(LV) function (Emax, maxdp/dt ) were measured at 3 time points (before CPB, 30min after re-beating, 60min after re-beating). Left ventricular specimens were taken for histologic examination at 30 min and 60min after re-beating.(Results) 1. ESPVR=Emax : FC group (before CPB 19.0*1.7mmHg/ml : 30min after re-beating 14.2*1.4 ; p<.0001 vs C Group, recovery rate=RR 73.4*11.3% : p<.000l vs C Group : 60min after re-beating 18.2*2.7, RR 96.0*7.1%). C group (before CPB 20.5*3.4 : 30min after re-beating 10.7*2.0, RR 52.9*11.4% : 60min after re-beating 18.2*3.9, RR 88.9*8.1%). 2.max dpfdt : FC group (before CPB 3555.3*349.3mmHg/s : 30mm after re-beating 2119.4*536.2, RR 59.9*14.5% 60min after re-beating 2859.7*126.4, RR 81.2*15.9%). C group (before CPB 2834.1*427.6 : 30min after re-beating 1357.5*107.6, RR 49.8*20.3% : 60min after re-beating 2436.0*142.7, RR 85.9*16.9%). No significant differences in max dp/dt values between two groups were detected. And no histological change in myocardiac tissues were detected in all specimens.(Conclusion) Although FC43se administration had effect on early recovery of the cardiac function after CPB, the satisfactory effect of FC43se could not be proved.
本研究旨在评估全氟三丁基胺/Pluronic F-68茎乳剂(FC43se)给药对体外循环(CPB)术后缺血心功能的影响。(方法)在CPB 60min后,将beagle犬心脏置于36oc热缺血状态30min。然后心脏又恢复了跳动。实验组分为两组。对照组(C)组(n=19)和FC43se给药组(n=14)在主动脉解夹前分别向主动脉根部注入10m1生理盐水和FC43se。在CPB前、复跳后30min、复跳后60min 3个时间点测量左室功能生理参数Emax、maxdp/dt。于复跳后30min和60min分别取左心室标本进行组织学检查。(结果)1。ESPVR=Emax: FC组(CPB前19.0*1.7mmHg/ml:复跳后30min 14.2*1.4; p< 0.0001,恢复率=RR 73.4*11.3%; p< 0.000l,与C组:复跳后60min 18.2*2.7, RR 96.0*7.1%)。C组(CPB前20.5*3.4;复跳后30min 10.7*2.0, RR 52.9*11.4%;复跳后60min 18.2*3.9, RR 88.9*8.1%)。2.最大dpfdt: FC组(CPB前3555.3*349.3mmHg/s,复跳30mm后2119.4*536.2,RR 59.9*14.5%,复跳60min后2859.7*126.4,RR 81.2*15.9%)。C组(CPB前2834.1*427.6;复跳后30min 1357.5*107.6, RR 49.8*20.3%;复跳后60min 2436.0*142.7, RR 85.9*16.9%)。两组间最大dp/dt值无显著差异。各组心肌组织均未见组织学改变。(结论)虽然给药FC43se对CPB术后心功能的早期恢复有一定作用,但其效果尚不能令人满意。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUURA Yuichiro其他文献
MATSUURA Yuichiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUURA Yuichiro', 18)}}的其他基金
The Usage and Origin of the Stone Implements in the Early Yayoi Period
弥生时代初期石器的用途及起源
- 批准号:
63450055 - 财政年份:1988
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
- 批准号:
23K21458 - 财政年份:2024
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a customed designed oxygenation system combined with novel therapy to treat reperfusion injury following Neurovascular Thrombectomy.
开发定制设计的氧合系统与新疗法相结合,治疗神经血管血栓切除术后的再灌注损伤。
- 批准号:
10057485 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Collaborative R&D
Development ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation
开发合成肝素以保护移植肝免受移植过程中的缺血再灌注损伤
- 批准号:
10759102 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Non-invasive imaging of reactive oxygen species in reperfusion injury myocardial infarction
再灌注损伤心肌梗死中活性氧的无创成像
- 批准号:
10716836 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Ischemia/Reperfusion injury and Myocardial edema
缺血/再灌注损伤和心肌水肿
- 批准号:
10718260 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Role of Gasdermin D/E in intestinal ischemia-reperfusion injury
Gasdermin D/E 在肠缺血再灌注损伤中的作用
- 批准号:
23K15529 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
STTR Phase I: Cardiotropic Atorvastatin Liposomes for Myocardial Reperfusion Injury
STTR 第一期:用于治疗心肌再灌注损伤的强心阿托伐他汀脂质体
- 批准号:
2300933 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Standard Grant














{{item.name}}会员




